Position in FATE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$73,899
+$27,992 QoQ
Shares Held
27,370
-28.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 156 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. FATE ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,899 | 27,370 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $45,907 | 38,256 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,808 | 11,029 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,040 | 11,937 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,608 | 23,758 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $13,339 | 16,886 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,300 | 14,728 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $24,097 | 6,885 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $72,543 | 22,117 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $60,195 | 8,201 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $56,971 | 15,233 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $86,550 | 40,826 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $118,085 | 24,808 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $56,019 | 9,828 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $83,343 | 8,260 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $1,211,013 | 54,039 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $183,024 | 7,386 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $482,221 | 12,438 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $230,879 | 3,946 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $216,630 | 3,655 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $281,373 | 3,242 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,895,360 | 22,988 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $655,696 | 7,211 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $112,875 | 2,824 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $415,802 | 12,119 | Shares | Other | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||